Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 410793, 11 pages
http://dx.doi.org/10.1155/2013/410793
Review Article

Extracts of Tripterygium wilfordii Hook F in the Treatment of Rheumatoid Arthritis: A Systemic Review and Meta-Analysis of Randomised Controlled Trials

Institute of Integrated Traditional Chinese and Western Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, 1095 Jiefang Avenue, Wuhan, Hubei 430030, China

Received 6 June 2013; Accepted 25 September 2013

Academic Editor: Xiang-Yu Hou

Copyright © 2013 Yafei Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Lee and M. E. Weinblatt, “Rheumatoid arthritis,” The Lancet, vol. 358, no. 9285, pp. 903–911, 2001. View at Publisher · View at Google Scholar · View at Scopus
  2. E. D. Harris Jr., “Rheumatoid arthritis: pathophysiology and implications for therapy,” New England Journal of Medicine, vol. 322, no. 18, pp. 1277–1289, 1990. View at Google Scholar · View at Scopus
  3. C. K. Kwoh, L. G. Anderson, J. M. Greene et al., “Guidelines for the management of rheumatoid arthritis: 2002 update—American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines,” Arthritis and Rheumatism, vol. 46, no. 2, pp. 328–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. G. S. Firestein, “Evolving concepts of rheumatoid arthritis,” Nature, vol. 423, no. 6937, pp. 356–361, 2003. View at Publisher · View at Google Scholar · View at Scopus
  5. J. S. Smolen, D. Aletaha, M. Koeller, M. H. Weisman, and P. Emery, “New therapies for treatment of rheumatoid arthritis,” The Lancet, vol. 370, no. 9602, pp. 1861–1874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. T. Bongartz, A. J. Sutton, M. J. Sweeting, I. Buchan, E. L. Matteson, and V. Montori, “Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies: systematic review and meta-analysis of rare harmful effects in randomized controlled trials,” Journal of the American Medical Association, vol. 295, no. 19, pp. 2275–2285, 2006. View at Publisher · View at Google Scholar · View at Scopus
  7. A. A. Kalla and M. Tikly, “Rheumatoid arthritis in the developing world,” Best Practice and Research: Clinical Rheumatology, vol. 17, no. 5, pp. 863–875, 2003. View at Publisher · View at Google Scholar · View at Scopus
  8. E. Yelin and L. A. Wanke, “An assessment of the annual and long-term direct costs of rheumatoid arthritis: the impact of poor function and functional decline,” Arthritis and Rheumatism, vol. 42, no. 6, pp. 1209–1218, 1999. View at Google Scholar
  9. X. Tao and P. E. Lipsky, “The Chinese anti-inflammatory and immunosuppressive herbal remedy Tripterygium wilfordii Hook F,” Rheumatic Disease Clinics of North America, vol. 26, no. 1, pp. 29–50, 2000. View at Google Scholar · View at Scopus
  10. X. Tao, J. J. Cush, M. Garret, and P. E. Lipsky, “A phase I study of ethyl acetate extract of the Chinese antirheumatic herb Tripterygium wilfordii Hook F in rheumatoid arthritis,” Journal of Rheumatology, vol. 28, no. 10, pp. 2160–2167, 2001. View at Google Scholar · View at Scopus
  11. W. Zhang, Q. Shi, L.D. Zhao et al., “The safety and effectiveness of a chloroform/methanol extract of Tripterygium wilfordii Hook F (T2) plus methotrexate in treating rheumatoid arthritis,” Journal of Clinical Rheumatology, vol. 16, no. 8, pp. 375–378, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. W. Ji, J. Li, Y. Lin et al., “Report of 12 cases of ankylosing spondylitis patients treated with Tripterygium wilfordii,” Clinical Rheumatology, vol. 29, no. 9, pp. 1067–1072, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. J. L. Guo, Z. G. Gao, A. C. Zang, and R. X. Bai, “Radix Tripterygium wilfordii Hook F in rheumatoid arthritis, ankylosing spondylitis and juvenile rheumatoid arthritis,” Chinese Medical Journal, vol. 99, no. 4, pp. 317–320, 1986. View at Google Scholar · View at Scopus
  14. T. Patavino and D. M. Brady, “Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus,” Alternative Medicine Review, vol. 6, no. 5, pp. 460–471, 2001. View at Google Scholar · View at Scopus
  15. X. Jiang, “Clinical observations on the use of the Chinese herb Tripterygium wilfordii Hook for the treatment of nephrotic syndrome,” Pediatric Nephrology, vol. 8, no. 3, pp. 343–344, 1994. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Ren, Q. Tao, X. Wang, Z. Wang, and J. Li, “Efficacy of T2 in active Crohn's disease: a prospective study report,” Digestive Diseases and Sciences, vol. 52, no. 8, pp. 1790–1797, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. S. Yang, J. Chen, Z. Guo et al., “Triptolide inhibits the growth and metastasis of solid tumors,” Molecular Cancer Therapeutics, vol. 2, no. 1, pp. 65–72, 2003. View at Google Scholar · View at Scopus
  18. A. M. Brinker, J. Ma, P. E. Lipsky, and I. Raskin, “Medicinal chemistry and pharmacology of genus Tripterygium (Celastraceae),” Phytochemistry, vol. 68, no. 6, pp. 732–766, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. X. Tao, J. J. Cai, and P. E. Lipsky, “The identity of immunosuppressive components of the ethyl acetate extract and chloroform methanol extract (T2) of Tripterygium wilfordii Hook.F,” Journal of Pharmacology and Experimental Therapeutics, vol. 272, no. 3, pp. 1305–1312, 1995. View at Google Scholar · View at Scopus
  20. H. Hu, A. Straub, Z. Tian, N. Bassler, J. Cheng, and K. Peter, “Celastrol, a triterpene extracted from Tripterygium wilfordii Hook F, inhibits platelet activation,” Journal of Cardiovascular Pharmacology, vol. 54, no. 3, pp. 240–245, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Wang, L. Ma, X. Tao, and P. E. Lipsky, “Triptolide, an active component of the Chinese herbal remedy Tripterygium wilfordii Hook F, inhibits production of nitric oxide by decreasing inducible nitric oxide synthase gene transcription,” Arthritis and Rheumatism, vol. 50, no. 9, pp. 2995–3003, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Tao, H. Schulze-Koops, L. Ma, J. Cai, Y. Mao, and P. E. Lipsky, “Effects of Tripterygium wilfordii Hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production,” Arthritis and Rheumatism, vol. 41, no. 1, pp. 130–138, 1998. View at Google Scholar
  23. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Google Scholar · View at Scopus
  24. A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  25. K. F. Schulz, L. Chalmers, R. J. Hayes, and D. G. Altman, “Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials,” Journal of the American Medical Association, vol. 273, no. 5, pp. 408–412, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. X. L. Tao, Y. Sun, Y. Dong et al., “A prospective, controlled, double-blind, cross-over study of Tripterygium wilfodii Hook F in treatment of rheumatoid arthritis,” Chinese Medical Journal, vol. 102, no. 5, pp. 327–332, 1989. View at Google Scholar · View at Scopus
  27. C. Huang, C. Wu, Z. Shen, M. Lin et al., “Study on the treatment of rheumatoid arthritis with polyglycosides of Tripterygium wilfordii Hook F: randomized, controlled, crossover clinical trial,” in Proceedings of the 3rd National Meeting of Rheumatology of China. Shijiazhuang, China, 1989, pp. 31–35, Chinese Association of Medicine, Beijing, China, 1989.
  28. X. Tao, J. Younger, F. Z. Fan, B. Wang, and P. E. Lipsky, “Benefit of an extract of Tripterygium wilfordii Hook F in patients with rheumatoid arthritis: a double-blind, placebo-controlled study,” Arthritis and Rheumatism, vol. 46, no. 7, pp. 1735–1743, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Fu, S. Liang, L. Ren, W. Li, and S. Guo, “The effect of tripterygium glycosides on plasma TNFα in patients with rheumatoid arthritis,” The Journal of Traditional Chinese Orthopedics and Traumatology, vol. 13, no. 9, pp. 13–14, 2001. View at Google Scholar
  30. N. Li, “The effect of tripterygium glycosides on plasma TNFα and IL-6 in patients with rheumatoid arthritis,” Journal of Guangxi Medical University, vol. 22, no. 5, pp. 681–683, 2005. View at Google Scholar
  31. Y. Tan, C. Wu, and Y. You, “Clinical analysis of methotrexate combined with penicillamine in the treatment of rheumatoid arthritis,” China Journal of Modern Medicine, vol. 10, no. 12, pp. 71–72, 2000. View at Google Scholar
  32. Y. Wang, Q. Wu, J. Wei, H. Shen, L. Wang, and Q. Zhu, “Total glucosides of paeony, methotrexate and Tripterygium wilfordii in the treatment of 150 cases of rheumatoid arthritis,” Journal of Zhengzhou University(Medical Sciences), vol. 41, no. 5, pp. 1002–1003, 2006. View at Google Scholar
  33. X. Yang and L. Zhang, “Clinical observation of tripterygium for treatment of 60 cases of rheumatoid arthritis,” Chinese Journal of Traditional Medical Science and Technology, vol. 14, no. 2, pp. 130–131, 2007. View at Google Scholar
  34. Z. Yang, “The clinic effect of Tripterygium wilfordii Hook F on rheumatoid arthritis,” China Pharmaceuticals, vol. 20, no. 14, pp. 76–77, 2011. View at Google Scholar
  35. J. Liu, H. Li, and X. Chen, “Effects of traditional Chinese medicine for invigorating spleen to resolve dampness and dredging collaterals on patients with rheumatoid arthritis and anemia,” Journal of Chinese Integrative Medicine, vol. 4, no. 4, pp. 348–354, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Goldbach-Mansky, M. Wilson, R. Fleischmann et al., “Comparison of Tripterygium wilfordii Hook F versus sulfasalazine in the treatment of rheumatoid arthritis: a randomized trial,” Annals of Internal Medicine, vol. 151, no. 4, pp. 229–240, 2009. View at Google Scholar · View at Scopus
  37. P. Chen, L. Zhu, X. Zou, H. Du, Y. Zhou, and X. Gu, “Tripterygium glucosides combined with methotrexate in treatment of rheumatoid arthritis: a randomised controlled trial,” Journal of Anhui Traditional Chinese Medical College, vol. 30, no. 6, pp. 28–32, 2011. View at Google Scholar
  38. N. Li and H. Ji, “Tripterygium wilfordii combines with sulfasalazine on the related indexes of active rheumatoid arthritis,” Journal of Liaoning University of Traditional Chinese Medicine, vol. 10, no. 12, pp. 89–90, 2008. View at Google Scholar
  39. D. T. Felson, J. J. Anderson, M. Boers et al., “American College of Rheumatology preliminary definition of improvement in rheumatoid arthritis,” Arthritis and Rheumatism, vol. 38, no. 6, pp. 727–735, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Cameron, J. J. Gagnier, and S. Chrubasik, “Herbal therapy for treating rheumatoid arthritis,” Cochrane Database of Systematic Reviews, no. 2, Article ID CD002948, 2011. View at Publisher · View at Google Scholar
  41. P. H. Canter, H. S. Lee, and E. Ernst, “A systematic review of randomised clinical trials of Tripterygium wilfordii for rheumatoid arthritis,” Phytomedicine, vol. 13, no. 5, pp. 371–377, 2006. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Little and T. Parsons, “Herbal therapy for treating rheumatoid arthritis,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD002948, 2000. View at Publisher · View at Google Scholar
  43. Q. Jiang, W. Cao, X. Tang, and J. Juan, “Tripterygium wilfordii extract for treating rheumatoid arthritis: systematic review,” China Journal of Chinese Materia Medica, vol. 34, no. 20, pp. 2637–2643, 2009. View at Google Scholar · View at Scopus
  44. K. F. Schulz and D. A. Grimes, “Blinding in randomised trials: hiding who got what,” The Lancet, vol. 359, no. 9307, pp. 696–700, 2002. View at Publisher · View at Google Scholar · View at Scopus
  45. K. F. Schulz and D. A. Grimes, “Allocation concealment in randomised trials: defending against deciphering,” The Lancet, vol. 359, no. 9306, pp. 614–618, 2002. View at Publisher · View at Google Scholar · View at Scopus